Semaglutide is a GLP-1 receptor agonist , a type of medication that mimics a natural hormone in your body to regulate appetite, slow gastric emptying, and promote insulin release
Study authors scoured the electronic health record of 18,386 people taking either Mounjaro or Ozempic between May 1, 2022 (the month Mounjaro received FDA approval) and September 30, 2023
Some providers defended offering access to the medication based on promising clinical trial data, while others removed references to retatrutide from their websites after being contacted by reporters
Plans are offered as a subscription that can be canceled at any time
Prescription weight loss injections are generally considered safe when prescribed and monitored by a qualified medical provider
So, that's very reassuring